| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b90a1752fda688689742d1e3b50f7962 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1992-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_797e80e706c7143573e4296a08b07fc5 |
| publicationDate |
1995-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SK-64492-A3 |
| titleOfInvention |
Piperazine derivatives, method of production and pharmaceutical compound containing them |
| abstract |
piperazinyl))-2-butyryl) -1H-azepine of formula (I) and its pharmaceutically acceptable acid addn. salts are new. Both enantiomers are claimed. |
| priorityDate |
1992-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |